Researchers create novel compound targeting melanoma cells
Boston University School of Medicine | Jan 12, 2018
KEYTRUDA® (pembrolizumab) significantly improved RFS as adjuvant therapy in patients with stage 3 resected high-risk melanoma
European Organisation for Research and Treatment of Cancer (EORTC) News | Jan 12, 2018
Female night shift workers may have increased risk of common cancers
American Association for Cancer Research News | Jan 12, 2018
New drug could 'shrink' harmful fat cells
Healthline/Medical News Today | Jan 11, 2018
What to eat for hypoglycemia
Healthline/Medical News Today | Jan 11, 2018
What you should know about breast cancer in teens
Healthline/Medical News Today | Jan 11, 2018
Diabetes: Can gene therapy normalize blood glucose levels?
Healthline/Medical News Today | Jan 11, 2018
Your gut microbes may give melanoma treatment a boost
Healthline/Medical News Today | Jan 11, 2018
Beta blockers may boost immunotherapy, help melanoma patients live longer
Pennsylvania State University Health and Medicine News | Jan 11, 2018
Clinical trial tests immunotherapy after surgery for pancreatic cancer
University of Colorado Health News | Jan 11, 2018